JOHANNESBURG — South Africa has started vaccinating children and adolescents as part of the global Phase 3 clinical trials of China’s Sinovac Biotech shot for children 6 months to 17 years.
The global study will enroll 2,000 participants in South Africa and 12,000 others in Kenya, the Philippines, Chile and Malaysia. The first children in South Africa were inoculated at the Sefako Makgatho Health Sciences University in the capital Pretoria to kick off the trials.
The Sinovac company says others will get shots at six different sites across the country.
South Africa has recorded 6,270 infections and 175 confirmed deaths in the last 24 hours. The 2.8 million total infections account for more than 35% of cases in Africa. The nation has 84,327 confirmed deaths.